Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LM-108 in advanced solid tumors
NCT05199753Phase 2Completed
- Sponsor
- LaNova Medicines
- Start
- Mar 2022
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
A Phase 2 trial of LM-108 in solid tumor (advanced stage), sponsored by LaNova Medicines. Started Mar 2022; status: completed.
02
Drugs
LM-108
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05199753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05199753.